SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-231204
Filing Date
2012-05-14
Accepted
2012-05-14 15:55:10
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d336986d10q.htm 10-Q 1146707
2 SECTION 302 CEO CERTIFICATION d336986dex311.htm EX-31.1 6377
3 SECTION 302 CFO CERTIFICATION d336986dex312.htm EX-31.2 6586
4 SECTION 906 CEO CERTIFICATION d336986dex321.htm EX-32.1 3319
5 SECTION 906 CFO CERTIFICATION d336986dex322.htm EX-32.2 3528
  Complete submission text file 0001193125-12-231204.txt   4091779

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isco-20120331.xml EX-101.INS 555651
7 XBRL TAXONOMY EXTENSION SCHEMA isco-20120331.xsd EX-101.SCH 26595
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20120331_cal.xml EX-101.CAL 41972
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20120331_def.xml EX-101.DEF 57586
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20120331_lab.xml EX-101.LAB 200451
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20120331_pre.xml EX-101.PRE 139689
Mailing Address 2595 JASON COURT OCEANSIDE CA 92056
Business Address 2595 JASON COURT OCEANSIDE CA 92056 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 12838589
SIC: 2834 Pharmaceutical Preparations